Yes, medical devices do require specific product certificates for NMPA (National Medical Products Administration) certification in China. The product certificate issued by NMPA is essential for legally marketing and selling medical devices in the Chinese market. This certificate demonstrates that a device has met China’s regulatory standards for safety, effectiveness, and quality.
This is the primary certificate issued by NMPA and is required for the market approval of medical devices in China. The Medical Device Registration Certificate is essentially the formal authorization for a manufacturer to legally sell and distribute a medical device within the country. It is issued after the device successfully meets NMPA's regulatory requirements, including compliance with Chinese standards and successful review of technical documents, clinical data (if required), and quality system audits.
For medical devices, especially Class II and III devices, manufacturers must demonstrate compliance with Good Manufacturing Practice (GMP) standards. A GMP certificate may be required as part of the NMPA registration process, particularly when the manufacturing site is located in China.
Foreign manufacturers: If the device is manufactured outside of China, the NMPA may require GMP certification for the foreign facility. This certification ensures that the manufacturing process adheres to international quality standards and that the facility is capable of producing medical devices consistently meeting safety and performance standards.
On-site Inspections: In some cases, NMPA may conduct on-site inspections of the manufacturing facilities to verify compliance with GMP and ensure quality control throughout the production process.
While not an official "product certificate" issued by NMPA, ISO 13485 certification plays a crucial role in the NMPA certification process. This international quality management system standard ensures that manufacturers have robust processes in place for ensuring the quality and safety of medical devices. NMPA may require a copy of the ISO 13485 certification as part of the submission documentation.
For Class II and III medical devices that require clinical trials to demonstrate their safety and efficacy, NMPA will issue an approval for conducting the clinical trial. This approval is an important step in obtaining final product certification for medical devices.
If clinical trials are needed, manufacturers must submit a clinical trial application to NMPA, detailing the study protocol and objectives. After the clinical trials are completed, the trial results must be submitted for NMPA’s review as part of the registration process.
Clinical Evaluation Report: A clinical evaluation report (CER) must be submitted as part of the registration process. This report evaluates the clinical performance of the device based on both the trial data (if applicable) and existing clinical literature. If no clinical trial is needed, existing international data may be used if deemed acceptable by NMPA.
For medical devices, especially higher-risk devices (Class II and III), product testing is an integral part of the NMPA certification process. The NMPA requires that the device undergo testing to demonstrate safety, performance, and compliance with Chinese GB standards (National Standards). These reports may be required in the following areas:
If a third-party testing lab conducts these tests, the reports must be issued by an accredited laboratory recognized by NMPA.
Before receiving a full Medical Device Registration Certificate, manufacturers must submit their product labels and instructions for use (IFU) for approval. These must be in Chinese and comply with NMPA requirements.
If the device’s labeling does not meet NMPA standards, the registration process can be delayed.
In addition to the Medical Device Registration Certificate, foreign manufacturers may need an import license issued by NMPA or the local Chinese customs authorities. This license allows the manufacturer to legally import the device into China.
These certificates and documentation are essential components of the NMPA registration process, and having them in order is crucial for a smooth approval process for entering the Chinese medical device market. Failure to provide the necessary certificates or meet specific requirements can result in delays or rejection of the application.
Contact Us:
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn